IVRO OTC
InVitro International
1W: +0.0%
1M: -14.3%
3M: -29.7%
YTD: -39.9%
1Y: +0.0%
3Y: -17.2%
5Y: -60.0%
$0.06
-0.01 (-7.69%)
Weekly Expected Move ±10.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$879K
+8.3% ▲
5Y CAGR: -4.5%
Gross Profit
$718K
+9.9% ▲
5Y CAGR: -4.4%
Operating Income
$87K
+27.4% ▲
5Y CAGR: +22.7%
Net Income
$122K
+14.3% ▲
5Y CAGR: +19.6%
EPS (Diluted)
$0.01
+17.8% ▲
5Y CAGR: +19.2%
EBITDA
$129K
+15.5% ▲
5Y CAGR: +14.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $854K | $793K | $811K | $879K |
| YoY Growth | -9.2% | -14.9% | -7.1% | +2.4% | +8.3% |
| Cost of Revenue | $199K | $173K | $157K | $158K | $161K |
| Gross Profit | $804K | $680K | $636K | $653K | $718K |
| Gross Margin | 80.1% | 79.7% | 80.2% | 80.6% | 81.7% |
| R&D Expenses | $112K | $88K | $13K | $54K | $46K |
| SG&A Expenses | $719K | $709K | $648K | $531K | $585K |
| Operating Expenses | $831K | $797K | $661K | $585K | $631K |
| Operating Income | -$27K | -$117K | -$25K | $68K | $87K |
| Operating Margin | -2.7% | -13.7% | -3.2% | 8.4% | 9.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $106K | $13K | $2K | $107K | $124K |
| Tax Expense | $10K | -$9K | $800 | $0 | $2K |
| Net Income | $96K | $21K | $2K | $107K | $122K |
| Net Margin | 9.6% | 2.5% | 0.2% | 13.2% | 13.9% |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
| EBITDA | $108K | $16K | $7K | $112K | $129K |
| Shares Outstanding | 23M | 23M | 24M | 24M | 23M |